About
Technology
Issues
FAQ
Links
Official Page
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.